Gilead Sciences (GILD) Other Operating Expenses (2009 - 2026)

Gilead Sciences (GILD) has reported Other Operating Expenses for 18 consecutive years, with $14.5 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Operating Expenses rose 728.31% year-over-year to $14.5 billion; the trailing twelve-month figure through Jun 2026 stood at $20.4 billion (up 127.72% YoY), and the FY2025 full-year result was $7.8 billion, down 48.01% from the prior year.
• Other Operating Expenses grew to $14.5 billion in Q2 2026 per GILD's latest filing, from $1.6 billion in the prior quarter.
• Across five years, Other Operating Expenses topped out at $14.5 billion in Q2 2026 and bottomed at $1.6 billion in Q1 2026.
• Historically, Other Operating Expenses has averaged $3.2 billion across 5 years, with a median of $1.8 billion in 2022.
• The sharpest annual moves came in 2025 and 2026: Other Operating Expenses slumped 77.9% in 2025, then jumped 728.31% in 2026.
• Over 5 years, Other Operating Expenses stood at $3.2 billion in 2022, then declined by 21.53% to $2.5 billion in 2023, then tumbled by 36.89% to $1.6 billion in 2024, then soared by 63.35% to $2.6 billion in 2025, then jumped by 466.21% to $14.5 billion in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $14.5 billion, $1.6 billion, and $2.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.